Literature DB >> 33245876

Interrelationships Among Small Airways Dysfunction, Neutrophilic Inflammation, and Exacerbation Frequency in COPD.

Kerry Day1, Kristoffer Ostridge2, Joy Conway3, Doriana Cellura4, Alastair Watson4, Cosma Mirella Spalluto4, Karl J Staples5, Bruce Thompson6, Tom Wilkinson5.   

Abstract

BACKGROUND: Small airways disease (SAD) is a key component of COPD and is a main contributing factor to lung function decline. RESEARCH QUESTION: Is SAD a key feature of frequent COPD exacerbators and is this related to airway inflammation? STUDY DESIGN AND METHODS: Thirty-nine COPD patients defined as either frequent exacerbator (FE) group (≥ 2 exacerbations/y; n = 17) and infrequent exacerbator (IFE) group (≤ 1 exacerbation/y; n = 22) underwent the forced oscillation technique (resistance at 5 Hz minus 19 Hz [R5-R19], area of reactance [AX]), multiple breath nitrogen washout (conducting airways ventilation heterogeneity, acinar ventilation heterogeneity [Sacin]), plethysmography (ratio of residual volume to total lung capacity), single-breath transfer factor of the lung for carbon monoxide, spirometry (FEV1, FEV1/FVC), and paired inspiratory-expiratory CT scans to ascertain SAD. A subpopulation underwent bronchoscopy to enable enumeration of BAL cell proportions.
RESULTS: Sacin was significantly higher in the COPD FE group compared with the IFE group (P = .027). In the FE group, markers of SAD were associated strongly with BAL neutrophil proportions, R5-R19 (P = .001, r = 0.795), AX (P = .049, ρ = 0.560), residual volume to total lung capacity ratio (P = .004, r = 0.730), and the mean lung density of the paired CT scans (P = .018, r = 0.639).
INTERPRETATION: Increased Sacin may be a consequence of previous exacerbations or may highlight a group of patients prone to exacerbations. Measures of SAD were associated strongly with neutrophilic inflammation in the small airways of FE patients, supporting the hypothesis that frequent exacerbations are associated with SAD related to increased cellular inflammation.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; exacerbation; inflammation; small airways

Year:  2020        PMID: 33245876     DOI: 10.1016/j.chest.2020.11.018

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.

Authors:  Alastair Watson; Jens Madsen; Howard William Clark
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

2.  Specialist respiratory outreach: a case-finding initiative for identifying undiagnosed COPD in primary care.

Authors:  Emma Ray; David Culliford; Helen Kruk; Kate Gillett; Mal North; Carla M Astles; Alexander Hicks; Matthew Johnson; Sharon Xiaowen Lin; Rosanna Orlando; Mike Thomas; Rachel E Jordan; David Price; Mita Konstantin; Tom M A Wilkinson
Journal:  NPJ Prim Care Respir Med       Date:  2021-02-11       Impact factor: 2.871

Review 3.  Respiratory viral infections in the elderly.

Authors:  Alastair Watson; Tom M A Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

Review 4.  Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease.

Authors:  Lee K Page; Karl J Staples; C Mirella Spalluto; Alastair Watson; Tom M A Wilkinson
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

5.  The role of clinical characteristics and pulmonary function testing in predicting risk of pneumothorax by CT-guided percutaneous core needle biopsy of the lung.

Authors:  Chunhai Li; Dexiang Wang; Fengxia Yang; Yang Song; Xuejuan Yu; Bo Liu; Haipeng Jia; Wei Zhou
Journal:  BMC Pulm Med       Date:  2021-08-06       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.